Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
2016
Infective Endocarditis
2005 Standout
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
2008
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Hepatocellular carcinoma
2003 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Hepatitis C and liver transplantation
2005 Nature
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Hepatocellular carcinoma
2018 Standout
Obesity, inflammation, and liver cancer
2011
Steatosis: Co-factor in Other Liver Diseases *
2005
Evaluation and stages of surgical innovations
2009 Standout
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
2012
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Hepatocellular carcinoma
2012 Standout
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
2004
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Left Lateral Segmentectomy for Pediatric Live-Donor Liver Transplantation: Special Attention to Segment IV Complications
2008
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Liver grafts from anti-hepatitis B core positive donors: A systematic review
2009
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
The metabolic syndrome
2005 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Non-alcoholic fatty liver disease
2021 Standout
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Treating hepatitis C
2005 StandoutNobel
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
2007
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis
2008
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
2004
Risk Factors for Primary Hepatocellular Carcinoma in Black and White Americans in 2000
2006
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
NAFLD, NASH and liver cancer
2013
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
2003
Obesity and diabetes as a risk factor for hepatocellular carcinoma
2004
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
NASH and HCC
2009
Trends in liver cancer mortality in China from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019
2023
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Introduction: The burden of hepatocellular carcinoma
2004
Vancomycin-Resistant Enterococcal Infections
2000 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Living‐Donor Liver Transplantation in the United States: Identifying Donors at Risk for Perioperative Complications
2007
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)
2018
Vancomycin-resistant enterococci: 15 years and counting
2003
Obesity and hepatocellular carcinoma
2004
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
2003
Hepatocellular Carcinoma
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Transplantation of Liver Grafts from Living Donors into Adults — Too Much, Too Soon
2001
Selection and Outcome of Living Donors for Adult to Adult Right Lobe Transplantation
2000
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Surveillance for Hepatocellular Carcinoma in Patients with NASH
2016
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation Study
2005
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Obesity-Associated Liver Disease
2008
Works of George E. Loss being referenced
Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis†
2004
Complications in 100 Living-Liver Donors
1998
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1
2003
INCIDENCE AND OUTCOME OF INFECTION BY VANCOMYCIN-RESISTANTENTEROCOCCUS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1998
Tolerance: Is It Worth the Risk?
2005
Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results
2001
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
2002
Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
2003
Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors
2014